FDA Permits Marketing of Mobile Medical Application for Substance Use Disorder

Friday, September 15, 2017

Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs. The application is not intended to be used to treat opioid dependence.

Learn the full details on the FDA’s website.